JP2007511837A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511837A5
JP2007511837A5 JP2006539990A JP2006539990A JP2007511837A5 JP 2007511837 A5 JP2007511837 A5 JP 2007511837A5 JP 2006539990 A JP2006539990 A JP 2006539990A JP 2006539990 A JP2006539990 A JP 2006539990A JP 2007511837 A5 JP2007511837 A5 JP 2007511837A5
Authority
JP
Japan
Prior art keywords
fragment
post
capture agent
fluid
pet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006539990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007511837A (ja
Filing date
Publication date
Priority claimed from US10/712,425 external-priority patent/US7460960B2/en
Application filed filed Critical
Publication of JP2007511837A publication Critical patent/JP2007511837A/ja
Publication of JP2007511837A5 publication Critical patent/JP2007511837A5/ja
Pending legal-status Critical Current

Links

JP2006539990A 2003-11-13 2004-11-15 プロテオームエピトームタグ及びそれらのタンパク質修飾分析における利用方法 Pending JP2007511837A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/712,425 US7460960B2 (en) 2002-05-10 2003-11-13 Proteome epitope tags and methods of use thereof in protein modification analysis
PCT/US2004/038283 WO2005050223A2 (en) 2003-11-13 2004-11-15 Proteome epitope tags and methods of use thereof in protein modification analysis

Publications (2)

Publication Number Publication Date
JP2007511837A JP2007511837A (ja) 2007-05-10
JP2007511837A5 true JP2007511837A5 (https=) 2008-01-10

Family

ID=34619853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539990A Pending JP2007511837A (ja) 2003-11-13 2004-11-15 プロテオームエピトームタグ及びそれらのタンパク質修飾分析における利用方法

Country Status (6)

Country Link
US (2) US7460960B2 (https=)
EP (1) EP1683065A2 (https=)
JP (1) JP2007511837A (https=)
AU (2) AU2004292226B2 (https=)
CA (1) CA2545899A1 (https=)
WO (1) WO2005050223A2 (https=)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113744A1 (en) * 2001-05-11 2003-06-19 O' Toole Margot M. Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
EP1415156B1 (en) 2001-07-10 2009-09-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of multiple proteins in single cells
US7695926B2 (en) 2001-07-10 2010-04-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting receptor-ligand interactions in single cells
US7381535B2 (en) * 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
FI118061B (fi) * 2001-09-24 2007-06-15 Beanor Oy Menetelmä ja bioanturi analyysiä varten
FI115166B (fi) * 2001-12-31 2005-03-15 Biofons Oy Diagnostisia menetelmiä
WO2004039830A2 (en) 2002-05-07 2004-05-13 Regents Of The University Of California Bioactivation of particles
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7632686B2 (en) 2002-10-03 2009-12-15 Anderson Forschung Group High sensitivity quantitation of peptides by mass spectrometry
US7846748B2 (en) * 2002-12-02 2010-12-07 The University Of North Carolina At Chapel Hill Methods of quantitation and identification of peptides and proteins
JP2007526213A (ja) * 2003-04-28 2007-09-13 セコイア、ファーマシューティカルズ、インコーポレイテッド コロナウイルスによる感染症の治療、管理および予防用の抗ウイルス剤
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US7790473B2 (en) * 2003-11-05 2010-09-07 The United States Of America As Represented By The Department Of Health And Human Services Biofunctionalized quantum dots for biological imaging
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
US20060154318A1 (en) * 2004-06-09 2006-07-13 Anderson Norman L Stable isotope labeled polypeptide standards for protein quantitation
US7943396B2 (en) * 2004-06-22 2011-05-17 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
US20060240227A1 (en) * 2004-09-23 2006-10-26 Zhijun Zhang Nanocrystal coated surfaces
JP2008516249A (ja) * 2004-10-12 2008-05-15 ショット アクチエンゲゼルシャフト マルチプレックスタンパク質吸着アッセイ
AU2006206159A1 (en) * 2005-01-24 2006-07-27 Massachusetts Institute Of Technology Method for modeling cell signaling systems by means of bayesian networks
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060223194A1 (en) * 2005-04-01 2006-10-05 Viorica Lopez-Avila Methods of screening for post-translationally modified proteins
US20060223130A1 (en) * 2005-04-04 2006-10-05 Dan-Hui Yang Detection of post-translationally modified analytes
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
EP1960364A2 (en) * 2005-12-07 2008-08-27 Ramot at Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
US20100331200A1 (en) * 2006-03-31 2010-12-30 Gordon Neal F Post translational modification pattern analysis
US20090269773A1 (en) * 2008-04-29 2009-10-29 Nodality, Inc. A Delaware Corporation Methods of determining the health status of an individual
US20090291458A1 (en) * 2008-05-22 2009-11-26 Nodality, Inc. Method for Determining the Status of an Individual
US8227202B2 (en) 2008-07-10 2012-07-24 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
WO2010045651A1 (en) * 2008-10-17 2010-04-22 Nodality, Inc. Methods for analyzing drug response
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
KR101061017B1 (ko) * 2009-10-23 2011-08-31 (주) 수파드엘릭사 암세포의 성장 및/또는 전이 억제용 약학 조성물
KR101341640B1 (ko) * 2010-02-05 2013-12-16 한국전자통신연구원 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
WO2012026309A1 (ja) * 2010-08-23 2012-03-01 公立大学法人横浜市立大学 抗ｐａｄ４抗体医薬の創成
US9068006B2 (en) 2010-08-25 2015-06-30 President And Fellows Of Harvard College Glycated CD59 peptides, their preparation, and uses thereof
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
BR112013020274A2 (pt) 2011-02-10 2016-11-22 Harvard College substitutos de proteínas pós-traducionalmente modificadas e usos dos mesmos
US9023599B2 (en) * 2011-09-25 2015-05-05 Chang Gung Medical Foundation, Linkou Branch Method of detecting the presence of pneumococcal neuraminidases in Streptococcus pneumoniae-infected samples
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9975922B2 (en) 2013-10-21 2018-05-22 The Research Foundation For The State University Of New York Peptide inhibitor of HIV reverse transcription
CN103698509B (zh) * 2014-01-08 2017-02-08 青岛科技大学 基于纳米多孔金片电极的电化学免疫传感器对巯基乙酸的检测
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
KR101750407B1 (ko) 2014-11-10 2017-06-27 한양대학교 산학협력단 프로틴 카이네이즈 a 기질 인산화펩타이드에 결합하는 알엔에이 앱타머
WO2016138381A1 (en) * 2015-02-27 2016-09-01 Regents Of The University Of Minnesota Detection assays and methods
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP6548981B2 (ja) * 2015-07-14 2019-07-24 地方独立行政法人東京都立産業技術研究センター 表面プラズモン共鳴測定装置及びそのチップ
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US10520514B2 (en) * 2017-02-01 2019-12-31 Korea Institute Of Science And Technology Method for monitoring post-translational modification of protein
SG11201909708VA (en) 2017-04-21 2019-11-28 Mellitus Llc Methods and antibodies for diabetes-related applications
EP3404567A1 (en) * 2017-05-19 2018-11-21 Fujitsu Limited A system and a method for discovery of predicted site-specific protein phosphorylation candidates
EP3661958A2 (en) * 2017-08-04 2020-06-10 Abcam Plc Methods and compositions for the development of antibodies specific to epitope post-translational modification status
CN108776231B (zh) * 2018-09-06 2020-12-29 长沙文瀚生物技术有限责任公司 一种人尿白蛋白胶乳增强二抗竞争免疫比浊检测试剂盒及其制作和使用方法
EP3640864A1 (en) * 2018-10-18 2020-04-22 Fujitsu Limited A computer-implemented method and apparatus for inferring a property of a biomedical entity
CN110209770B (zh) * 2019-06-03 2022-04-15 北京邮电大学 一种基于策略价值网络和树搜索增强的命名实体识别方法
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法
US12285437B2 (en) 2019-10-30 2025-04-29 The Research Foundation For The State University Of New York Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity
CN113899902B (zh) * 2020-06-22 2024-10-29 上海科技大学 一种酪氨酸磷酸酶底物鉴定方法
CN112305041B (zh) * 2020-09-15 2022-05-27 东莞东阳光医疗智能器件研发有限公司 多重定量电化学免疫传感器及其构建方法
WO2022066992A1 (en) * 2020-09-24 2022-03-31 University Of Cincinnati Continuous sensing with adapters and aptamers
US11617741B1 (en) 2021-08-12 2023-04-04 Health Research, Inc. Method for inhibiting growth of bacteria
WO2023025263A1 (en) * 2021-08-25 2023-03-02 Ensem Therapeutics Holding (Singapore) Pte. Ltd. Systems and methods for post-translational modification-inspired drug design and screening
JP2023121226A (ja) * 2022-02-21 2023-08-31 株式会社日立製作所 検体の前処理方法及びその応用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478744A (en) * 1982-01-25 1984-10-23 Sherwood Medical Company Method of obtaining antibodies
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
EP0267355B1 (de) 1986-11-10 1991-09-18 PROGEN Biotechnik GmbH Verfahren zum Identifizieren gewebstypischer, unlöslicher Cytoskelettproteine
DE3815932A1 (de) 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
US4970171A (en) * 1987-11-09 1990-11-13 Miles Inc. Denaturant reagents for convenient determination of hemoglobin derivatives in blood
US5849531A (en) * 1989-04-07 1998-12-15 University Of Saskatchewan Compositions and treatments for pneumonia in animals
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US5061790A (en) * 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
DE4009848A1 (de) * 1990-03-27 1991-10-02 Boehringer Mannheim Gmbh Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
DE4023945A1 (de) 1990-07-27 1992-01-30 Progen Biotechnik Gmbh Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
WO1993008290A1 (en) * 1991-10-16 1993-04-29 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
HUT71860A (en) * 1992-08-27 1996-02-28 Deakin Res Ltd Retro-, inverso-, and retro-inverso synthetic peptide analogues
WO1994008597A1 (en) 1992-10-14 1994-04-28 The Scripps Research Institute Methods for the detection of antigen-specific immune complexes
US5955317A (en) * 1993-01-25 1999-09-21 Takeda Chemical Industries, Ltd. Antibodies to β-amyloids or their derivatives and use thereof
JPH07285999A (ja) 1993-03-30 1995-10-31 Prima Meat Packers Ltd Ｅｌｉｓａを用いた食品中の乳蛋白質含量の定量分析方法及びその分析用に選別されたモノクローナル抗体及びそのモノクローナル抗体の選別方法
JP3393889B2 (ja) * 1993-06-11 2003-04-07 柳川精工株式会社 無潤滑軸受の製造方法および無潤滑軸受
EP0767379A1 (de) 1993-06-22 1997-04-09 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Diagnose und Analyse von Kolonkarzinomen
WO1996005847A1 (en) 1994-08-22 1996-02-29 The Trustees Of The University Of Pennsylvania A method of sequencing proteins by epitope ordering and protein restriction mapping
EP0812434B1 (en) 1995-03-01 2013-09-18 President and Fellows of Harvard College Microcontact printing on surfaces and derivative articles
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
AUPN480095A0 (en) 1995-08-15 1995-09-07 Commonwealth Scientific And Industrial Research Organisation Epitope tagging system
JP3452111B2 (ja) * 1995-11-10 2003-09-29 セイコーエプソン株式会社 インクジェット式記録ヘッド
US6420125B1 (en) * 1996-03-21 2002-07-16 Osteometer Biotech A/S Assaying fragments of collagen in body fluids
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5872234A (en) * 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US6253456B1 (en) * 1997-11-17 2001-07-03 Phillip Cooksey Basketball court layout device and method
US6809184B1 (en) * 1997-12-01 2004-10-26 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
DE19802576B4 (de) 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
CA2319828A1 (en) 1998-01-29 1999-08-05 Miller, Samuel High density arrays for proteome analysis and methods and compositions therefor
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6897073B2 (en) 1998-07-14 2005-05-24 Zyomyx, Inc. Non-specific binding resistant protein arrays and methods for making the same
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
JP2002535676A (ja) 1999-01-28 2002-10-22 ユニヴェルシテ ドゥ ジュネーブ ポリペプチドを同定または特徴付けるための方法およびキット
CA2365431A1 (en) 1999-03-10 2000-09-14 Hui Ge Universal protein array system
US20020132753A1 (en) * 2000-01-31 2002-09-19 Rosen Craig A. Nucleic acids, proteins, and antibodies
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
WO2002006834A2 (en) 2000-07-19 2002-01-24 Pointilliste, Inc. Nested sorting and high throughput screening
GB0022978D0 (en) * 2000-09-19 2000-11-01 Oxford Glycosciences Uk Ltd Detection of peptides
US7142296B2 (en) * 2000-10-30 2006-11-28 Sru Biosystems, Inc. Method and apparatus for detecting biomolecular interactions
DE10054055A1 (de) * 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
WO2002039083A2 (en) * 2000-11-08 2002-05-16 Science & Technology Corporation @ Unm Fluorescence and fret based assays for biomolecules on beads
IL140881A0 (en) * 2001-01-14 2002-02-10 Katz Emil Israel A method for identification and quantification of proteins in a biopsy or other tissue sample and a kit for use thereof
GB0103389D0 (en) * 2001-02-12 2001-03-28 Novartis Ag Organic compounds
WO2002086081A2 (en) * 2001-04-20 2002-10-31 Carnegie Mellon University Methods and systems for identifying proteins
US20030044862A1 (en) * 2001-06-22 2003-03-06 The Board Of Trustees Of The Leland Stanford Jr. University Diagnostic marker for tumor hypoxia and prognosis
IL159550A0 (en) 2001-06-26 2004-06-01 Mds Proteomics Inc Methods and systems for identifying kinases, phosphatases and substrates thereof
EP1417626A2 (en) * 2001-07-13 2004-05-12 Pharmacopeia, Inc. System and method for aqueous solubility prediction
US20030143612A1 (en) 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
WO2003016904A2 (en) * 2001-08-13 2003-02-27 Campbell Douglas A Peptide sequence tags and method of using same
US20050153298A1 (en) * 2001-10-23 2005-07-14 Gembitsky Dmitry S. Protein micro-arrays and multi-layered affinity interaction detection
GB0200595D0 (en) 2002-01-11 2002-02-27 Oxford Glycosciences Uk Ltd Quantitation of differential expression
US20040038307A1 (en) * 2002-05-10 2004-02-26 Engeneos, Inc. Unique recognition sequences and methods of use thereof in protein analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US20060014212A1 (en) * 2002-05-10 2006-01-19 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7618788B2 (en) 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US20040229284A1 (en) * 2003-02-19 2004-11-18 The Regents Of The University Of California Multiplex analysis of proteins
US20050255491A1 (en) * 2003-11-13 2005-11-17 Lee Frank D Small molecule and peptide arrays and uses thereof
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
US20100331200A1 (en) 2006-03-31 2010-12-30 Gordon Neal F Post translational modification pattern analysis

Similar Documents

Publication Publication Date Title
JP2007511837A5 (https=)
JP6553142B2 (ja) タンパク質のグリコシル化の評価による肝臓病変の診断
TWI281473B (en) Biomarkers for liver diseases and method for using same
CN107110867A (zh) 用于肝癌诊断的生物标记物及其用途
AU726738B2 (en) Diagnosis of epithelial cell abnormalities
JP2008509379A (ja) 活性化可能な遊離型ｐｓａの検出方法、並びに、前立腺の良性病状及び前立腺ガンの診断におけるその使用
KR102702698B1 (ko) 암의 진단용 조성물
Frascione et al. Fluorogenic displacement biosensors for PSA detection using antibody-functionalised quantum dot nanoparticles
KR20110038778A (ko) 다중렉틴을 이용한 체액 유래 단백질 동정 방법 및 이 방법에 의하여 탐지된 간암 바이오마커
CN101356439A (zh) 纤维化标记
WO2016093567A1 (ko) 간암 진단용 바이오마커 및 그 용도
US8183004B2 (en) Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
WO2019242741A1 (en) Biomarkers for urothelial carcinoma and applications thereof
CN112534262A (zh) 检测手足口病的方法
KR101832039B1 (ko) 간암 표적치료제 반응 예측용 바이오마커 및 그 용도
JP4724816B2 (ja) タンパク質の測定方法
JP2022110148A (ja) 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
US20160018415A1 (en) Marker for diagnosing diabetic retinopathy and use therof
WO2023004626A1 (zh) 一种骨髓瘤生物标志物serpinf2及其应用
KR20170100213A (ko) 신장암 진단용 조성물과 진단 마커 검출 방법
EP1540342B1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
JP5640271B2 (ja) 新規ペプチド及びその使用
WO2016093629A1 (ko) 간암 표적치료제 반응 예측용 바이오마커 및 그 용도
AU2015275300B2 (en) Diagnosis of liver pathology through assessment of protein glycosylation
KR20240154464A (ko) 암의 진단용 조성물